Use of HER2 gene amplification to identify patients with metastatic colorectal cancer resistant to anti-EGFR monoclonal antibodies.

被引：4
|
作者：
Barbara, Cecilia
Martin, Vittoria
Molinari, Francesca
Landi, Lorenza
Riva, Alice
Saletti, Piercarlo
de Dosso, Sara
Geva, Ravit
Tejpar, Sabine
Fountzilas, George
Kalogeras, Konstantine T.
Frattini, Milo
Cappuzzo, Federico
机构：
[1] Osped Civile Livorno, Dept Med Oncol, Livorno, Italy
[2] Ist Cantonale Patol, Lab Mol Diagnost, Locarno, Switzerland
[3] Osped San Giovanni Bellinzona, Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[4] Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[5] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[6] Univ Hosp Gasthuisberg, Leuven, Belgium
[7] Hellen Cooperat Oncol Grp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
474
引用
收藏
页数：2
相关论文
共 50 条
  • [1] HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients
    Martin, V.
    Landi, L.
    Molinari, F.
    Fountzilas, G.
    Geva, R.
    Riva, A.
    Saletti, P.
    De Dosso, S.
    Spitale, A.
    Tejpar, S.
    Kalogeras, K. T.
    Mazzucchelli, L.
    Frattini, M.
    Cappuzzo, F.
    BRITISH JOURNAL OF CANCER, 2013, 108 (03) : 668 - 675
  • [2] HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients
    V Martin
    L Landi
    F Molinari
    G Fountzilas
    R Geva
    A Riva
    P Saletti
    S De Dosso
    A Spitale
    S Tejpar
    K T Kalogeras
    L Mazzucchelli
    M Frattini
    F Cappuzzo
    British Journal of Cancer, 2013, 108 : 668 - 675
  • [3] HER2 Amplification and Anti-EGFR Sensitivity in Advanced Colorectal Cancer
    Bregni, Giacomo
    Sciallero, Stefania
    Sobrero, Alberto
    JAMA ONCOLOGY, 2019, 5 (05) : 605 - 606
  • [4] Heterogeneity of acquired KRAS and EGFR mutations in colorectal cancer patients treated with anti-EGFR monoclonal antibodies.
    Morelli, M. Pia
    Overman, Michael J.
    Dasari, Arvind
    Kazmi, Syed Mohammad Ali
    Sanchez, Eduardo Vilar
    Eng, Cathy
    Kee, Bryan K.
    Deaton, Laurel
    Garrett, Chris R.
    Diehl, Frank
    Angenendt, Philipp
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Amplification of MET gene in anti-EGFR resistant colorectal cancer
    Bond, Theo
    PHARMACOGENOMICS, 2013, 14 (11) : 1249 - 1249
  • [6] Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
    Pietrantonio, Filippo
    Vernieri, Claudio
    Siravegna, Giulia
    Mennitto, Alessia
    Berenato, Rosa
    Perrone, Federica
    Gloghini, Annunziata
    Tamborini, Elena
    Lonardi, Sara
    Morano, Federica
    Picciani, Benedetta
    Busico, Adele
    Volpi, Chiara Costanza
    Martinetti, Antonia
    Battaglin, Francesca
    Bossi, Ilaria
    Pellegrinelli, Alessio
    Milione, Massimo
    Cremolini, Chiara
    Di Bartolomeo, Maria
    Bardelli, Alberto
    de Braud, Filippo
    CLINICAL CANCER RESEARCH, 2017, 23 (10) : 2414 - 2422
  • [7] MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies
    Cappuzzo, Federico
    Sacconi, Andrea
    Landi, Lorenza
    Ludovini, Vienna
    Biagioni, Francesca
    D'Incecco, Armida
    Capodanno, Alessandra
    Salvini, Jessica
    Corgna, Enrichetta
    Cupini, Samanta
    Barbara, Cecilia
    Fontanini, Gabriella
    Crino, Lucio
    Blandino, Giovanni
    CLINICAL COLORECTAL CANCER, 2014, 13 (01) : 37 - U62
  • [8] Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer
    G. Wang
    Y. He
    Y. Sun
    W. Wang
    X. Qian
    X. Yu
    Y. Pan
    Clinical and Translational Oncology, 2020, 22 : 813 - 822
  • [9] Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer
    Wang, G.
    He, Y.
    Sun, Y.
    Wang, W.
    Qian, X.
    Yu, X.
    Pan, Y.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (06): : 813 - 822
  • [10] Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach?
    Fakih, Marwan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (09) : 1471 - 1480
12345